- Academic Editor
-
-
-
Background: Polycystic ovarian syndrome (PCOS) is a chronic
endocrinopathy of unexplained etiology linked to obesity. Neuregulin 4 (NG-4) is
an adipokine synthesized primarily by brown adipose tissue; that keeps glucose
and lipids in hemostasis. Earlier research tested serum NG-4 correlation with
metabolic parameters in PCOS; herein, we aimed to examine serum NG-4 validity as
a marker for PCOS with respect to obesity parameters and the influence of obesity
on NG-4 concentrations. Methods: A cross-sectional study recruited 120
women into two groups; PCOS cases (60/120) and healthy controls (60/120). For
every participant, three sets of data were recorded; anthropometric data (age,
height, and weight for calculation of body mass index (BMI), waist/hip ratio, and
systolic and diastolic blood pressure) hormonal levels, including serum
(luteinizing hormone/follicle-stimulating hormone (LH/FSH) ratio, prolactin,
anti-Mullerian hormone (AMH), testosterone, and insulin) and biochemical
biomarkers (fasting blood sugar, Homeostatic Model Assessment for Insulin
Resistance (HOMA-IR), high and low-density lipoproteins (HDL and LDL), and NG-).
Results: Serum NG-4 levels were significantly higher among PCOS
vs. healthy controls. The univariant analysis confirmed a significant
correlation of NG-4 to BMI, hormonal, and metabolic parameters. None of the
obesity parameters were correlated with serum NG-4; only PCOS had an effect on
serum NG-4 with p